Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abnormal, accomplishment, addressed, addressing, anterior, arisen, Black, BlackRock, blink, blurred, bore, bundled, burn, calcineurin, Chinese, Clarifying, CLO, compensatory, contraindicated, core, CorMedix, corneal, cytokine, digit, driven, duly, expedient, faith, feedback, fibrotic, forecast, Fosum, gastrointestinal, gevokizumab, glucocorticoid, hedging, highest, Humira, immunomodulatory, Indenture, Insider, interior, interleukin, intermediate, invoiced, irritation, kinase, knockout, knowhow, Linkbase, lipid, MCr, mix, monetization, monoclonal, mucin, nicotinic, nonrefundable, Norway, omitted, pan, Poland, polymer, posterior, preceding, proxy, radiolabeled, ratification, rounding, Schema, seventeen, signaling, situated, Supplementary, swelling, Taxonomy, thereunto, tissue, tract, tradename, Transplantation, Turkey, uncontrolled, undersigned, vision, Vylessi, wall, XBRL
Removed:
abdomen, accredited, acutely, agent, allocated, amenable, amortizing, analog, antihypertensive, Antyra, arousal, audibly, body, carperitide, circulation, clinically, collar, Colombia, congestive, contracted, corin, declare, decompensated, dedicated, defer, deferral, designated, diagnosed, diverse, dyspnea, ejection, enalapril, Eurasian, FDCA, fraction, Greece, HFpEF, HFrEF, higher, hospitalization, Hungary, implement, improving, inherently, inhibition, inhibitor, initially, insulin, intravenously, investigated, ion, Lonza, LP, Luxembourg, minimal, MKT, Monaco, naturally, needle, neuronal, nineteen, noncurrent, objective, occurring, parachute, persistent, pharmacodynamic, physiologic, pool, poor, Portugal, preserved, pressing, QVT, reached, ready, remodeling, repurchase, rest, retire, retracted, room, showed, significance, skin, statistical, stored, structured, subcutaneously, temperature, thigh, tool, ularitide, upregulated, upregulation, urodilatin, verify, visible, vitro, volunteer, voted, wide, Ypsomed
Filing tables
Filing exhibits
- 10-K Annual report
- 4.12 Instruments Defining the Rights of Security Holders, Including Indentures Instruments Defining the Rights of Security Holders, Including Indentures
- 21 Subsidiaries of the Registrant
- 23 Consents of Experts and Counsel
- 31.1 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 31.2 Certification Pursuant to Rule 13A-14(A)/15D-14(A) Certifications Section 302 of the Sarbanes-oxly Act of 2002
- 32.1 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 Certificate Pursuant to Section 18 U.s.c. Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
Associated PTN transcripts
PTN similar filings
Filing view
External links
EXHIBIT 32.2
Certification of Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Stephen T. Wills, Executive Vice President, Chief Financial Officer and Chief Operating Officer of Palatin Technologies, Inc., hereby certify, to my knowledge, that the Annual Report on Form 10-K for the year ended June 30, 2019 of Palatin Technologies, Inc. (the “Form 10-K”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of Palatin Technologies, Inc.
Dated: September 12, 2019
/s/ Stephen T. Wills |
Stephen T. Wills, Executive Vice President, Chief Financial Officer and Chief Operating Officer (Principal Financial Officer) |